February 2001

International society for heart and lung transplantation

Scientific program committee

Abstract reviewers

Continuing medical education information

General meeting information

Highlights of the scientific program

Sponsors

Index to authors of abstracts

Program section

Familial and sporadic primary pulmonary hypertension is caused by BMPR2 gene mutations resulting in haploinsufficiency of the bone morphogenetic protein tùype II receptor

• J. Thomson,
• R. Machado,
• M. Pauciulo,
• ...
• J. Loyd,
• W. Nichols,
• R. Trembath

Immunolocalisation of BMPR-II and TGF-ß type I and II receptors in primary plexogenic pulmonary hypertension

• C. Atkinson,
• S. Stewart,
• T. Imamura,
• R.C. Trembath,
• N.W. Morrell

One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation

• P. Corris,
• A. Glanville,
• K. McNeil,
• ...
• L. Eriksson,
• O. Geiran,
• R. Guillemain

CTLA4Ig and donor-specific transfusion prolongs cardiac allograft survival in the miniature swine

• R.S. Lee,
• J.R. Rusche,
• L.A. Cheatham,
• ...
• J.B. Mezrich,
• M.H. Sayegh,
• J.C. Madsen

Prognostic value of a new intravascular ultrasound score in graft vessel disease

• J. Segovia,
• L. Alonso-Pulpon,
• J. Escaned,
• ...
• C. Bañuelos,
• M. Sabate,
• C. Macaya

Usefulness of post-transplant wall motion analysis by tissue Doppler imaging in patients with cardiac allograft vasculopathy: evaluation of functional severity and timing of follow-up cardiac catheterizations

• M. Dandel,
• M. Hummel,
• E. Wellnhofer,
• J. Müller,
• R. Ewert,
• R. Hetzer

Haptoglobin polymorphism influences the development of cardiac transplant vasculopathy

• C.G. Densem,
• J. Wassel,
• N.H. Brooks,
• N. Yonan,
• B. Keevil

Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients

• M.R. Costanzo,
• H.J. Eisen,
• R.N. Brown,
• ...
• S. Davis,
• M. Mccloud,
• J. Kirklin

Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation

• M.P. Pelletier,
• M. Coady,
• M. Macha,
• P.E. Oyer,
• R.C. Robbins

In vivo donor adenoviral-mediated transtracheal transfection of human IL-10 (HIL-10) gene ameliorates ischemia-reperfusion (IR) injury and enhances transplanted lung function.

• S. Fischer,
• M. Liu,
• A.A. Maclean,
• ...
• J. Cardella,
• Y. Imai,
• S. Keshavjee

First results 24 hours after orthotopic heart transplantation from non-heart-beating donors in pigs

• J.R. Martin,
• G.F. Lutter,
• M.R. Siepe,
• ...
• K.A. Sarai,
• C.H. Ihling,
• F.R. Beyersdorf

Endothelial function after brain death

• G. Szabo,
• V. Buhmann,
• C.F. Vahl,
• C. Sebening,
• S. Hagl

Recipient treatment with trimetazidine improves graft function and protects the energy status after lung transplantation

• I. Inci,
• A. Dutly,
• A. Boehler,
• W. Weder

Upregulation of BCL-2 via hyperbaric pressure transfection of TGF- β1 ameliorates ischemia/reperfusion injury in rat cardiac allografts

• J. Grunenfelder,
• D. Miniati,
• S. Murata,
• ...
• E.G. Hoyt,
• M. Koransky,
• R. Robbins

Improvement of cardiac allograft function by 1400W, a highly selective inducible nitric oxide synthase inhibitor and superoxide dismutase − role of peroxynitrite

• K. Egi,
• N.E. Conrad,
• A. Bedynek,
• P. Ferdinandy,
• B. Reichart,
• S.M. Wildhirt

Biopsy diagnosis of disease recurrence after transplantation (TX) for pulmonary sarcoidosis: a multicentre study

• M. Burke,
• S. Stewart,
• T. Ashcroft,
• C. Corbishley,
• P. Bishop,
• C. Kjellstrom

Interstitial pneumonitis after lung or heart-lung transplantation in very young recipients

• T.M. Hoffman,
• N.D. Bridges,
• P.A. Russo,
• T.L. Spray

Nonimmunologic rejection of the heart

• C.A. Labarrere

Anti-thymocyte globulin treatment is associated with complement deposition in early cardiac transplant biopsies

• W.M. Baldwin,
• L.P. Armstrong,
• M.D. Samaniego,
• ...
• J.V. Conte,
• E.R. Rodriguez,
• R.H. Hruban

Vascular endothelial growth factor-D (VEGF-D) is an endothelial hyperpermeability inducing growth factor differentially expressed in human cardiac allografts

• D. Wong,
• J. Luckhurst,
• H. Toma,
• ...
• A. Suarez,
• J.E. Wilson,
• B.M. McManus

Sustained production of the chemokine MIG precedes intimal thickening in chronic rejection

• J.J. Yun,
• M.P. Fischbein,
• H. Laks,
• ...
• R. Strieter,
• J.A. Berliner,
• A. Ardehali

Early T lymphocyte trafficking after allo-transplantation

• J. Legare,
• G.M. Hirsch,
• T.B. Issekutz

A novel scavenger of nitric oxide decreases heme protein nitrosylation and prolongs graft survivial during cardiac transplant rejection

• G.M. Pieper,
• A.M. Roza,
• M.B. Adams,
• ...
• G. Hilton,
• C.C. Felix,
• S.P. Fricker

IL-4 promotor gene polymorphism in heart transplantation

• F. Bijlsma,
• J. Van Kuik,
• N. De Jonge,
• ...
• A. Bruggink,
• F.Gmelig- Meyling,
• R. De Weger

Matrixmetalloproteinase (MMP) 9 activity and impaired coronary vasomotor function after cardiac transplantation in rats.

• S.M. Wildhirt,
• K. Egi,
• C. Knosalla,
• ...
• C.J. Schulze,
• R. Schulz,
• B. Reichart

Indirect allorecognition and alloantibody production precede obliterative airway disease development after tracheal transplantation in mice

• M. Smith,
• K. Sivasai,
• B. Naziruddin,
• Z. Kaleem,
• G. Patterson,
• T. Mohanakumar

Lung transplantation for cystic fibrosis; the effect of B cepacia genomovars on post transplant outcomes

• A. De Soyza,
• L. Archer,
• A. McDowell,
• ...
• E. Mahenthiralingam,
• P.A. Corris,
• K. Gould

Oxidative stress of cardiac transplantation is associated with decreased BCL-2 expression and increased NFKB activity

• D.N. Miniati,
• J. Grunenfelder,
• E.G. Hoyt,
• ...
• M. Kown,
• M. Koransky,
• R. Robbins

Impairment of cytolytic activity in allograft environment affects early medial cell loss but does not alter outcome of allograft arteriosclerosis

• J.L. O’Neill,
• J.L. Jordan,
• J. Zhou,
• T.D. Lee,
• G.M. Hirsch

Elevation of serum big endothelin is associated with endothelial dysfunction in patients with chronic heart failure

• R. Berger,
• K. Strecker,
• B. Stanek,
• M. Huelsmann,
• R. Pacher,
• T. Neunteufl

Tumour necrosis factor- a A2 polymorphism; a predisposing factor to non-ischaemic myocardial dysfunction?

• C. Densem,
• I.V. Hutchinson,
• N. Yonan,
• N.H. Brooks

A dominant negative isoform of the serum-response factor (SRF) is increased in the failing human heart

• M. Gupta,
• F.J. Davis,
• D. Jayakar,
• V. Jeevananadam

The effects of mycophenolate mofetil on cardiac allograft survival and cardiac allograft vasculopathy in miniature swine

• M.L. Schwarze,
• J.D. Mezrich,
• M.T. Menard,
• ...
• E.P. Pillsbury,
• D.H. Sachs,
• J.C. Madsen

Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure

• T. Van Gelder,
• J. Klupp,
• M.J. Barten,
• U. Christians,
• R.E. Morris

ISATX247: a novel calcineurin inhibitor

• M.D. Abel,
• L.J. Aspeslet,
• D.G. Freitag,
• ...
• N.M. Kneteman,
• R.T. Foster,
• R.W. Yatscoff

Eotaxin and prednisolone concentrations regulate the mobilisation of peripheral blood eosinophils preceding heart allograft rejection

• A.K. Trull,
• S.C. Charman,
• S. Endenburg,
• ...
• L.A. Steel,
• J. Parameshwar,
• J. Wallwork

Cyclosporine verus tacrolimus in heart transplantation: an ISHLT/UNOS registry analysis

• J.D. Hosenpud,
• L.E. Bennett

Current practices: immunosuppression induction, maintenance and rejection regimens in 213 consecutive transplant recipients

• A. Gass,
• H. Eisen,
• B. Griffith,
• ...
• J. Young,
• E. Gilb,
• S. Tuteja

Early experience with sirolimus in lung transplant recipients

• B. Cahill,
• J. Crompton,
• T. Somerville,
• ...
• S. Parker,
• J. Stringham,
• S. Karwande